These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25039933)

  • 41. [Treatment of hemophilia].
    Straub PW
    Dtsch Med Wochenschr; 1969 Sep; 94(37):1885-7. PubMed ID: 5356323
    [No Abstract]   [Full Text] [Related]  

  • 42. [Traceability of labile blood products in Morocco: experience of the Ibn-Sina hospital of Rabat between 1999 and 2010].
    Ouadghiri S; Atouf O; Brick C; Benseffaj N; Essakalli M
    Transfus Clin Biol; 2012 Feb; 19(1):1-4. PubMed ID: 22269085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The chiasm: transfusion practice versus patient blood management.
    Spahn DR; Shander A; Hofmann A
    Best Pract Res Clin Anaesthesiol; 2013 Mar; 27(1):37-42. PubMed ID: 23590914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Principles of modern therapy for hemophilia A and B in childhood].
    Ströder J; Ambs E
    Dtsch Med Wochenschr; 1968 Mar; 93(12):539-41. PubMed ID: 5639667
    [No Abstract]   [Full Text] [Related]  

  • 45. Patient blood management: the pragmatic solution for the problems with blood transfusions.
    Spahn DR; Moch H; Hofmann A; Isbister JP
    Anesthesiology; 2008 Dec; 109(6):951-3. PubMed ID: 19034088
    [No Abstract]   [Full Text] [Related]  

  • 46. Barriers and enablers to introducing comprehensive patient blood management in the hospital.
    Mbanya D
    Biologicals; 2012 May; 40(3):205-8. PubMed ID: 22316645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Research and development commitments in an integrated plasma collection and plasma fractionation environment.
    Radosevich M
    Semin Thromb Hemost; 1998; 24(2):157-61. PubMed ID: 9579637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review of current transfusion therapy and blood banking practices.
    Storch EK; Custer BS; Jacobs MR; Menitove JE; Mintz PD
    Blood Rev; 2019 Nov; 38():100593. PubMed ID: 31405535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is self-sufficiency financially viable and ethically justifiable?--the role of the National Blood Authority.
    Adey J
    Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 4():S35-6. PubMed ID: 7795136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The dynamics of contract plasma fractionation.
    Farrugia A; Scaramuccia D
    Biologicals; 2017 Mar; 46():159-167. PubMed ID: 28236560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of non-operative management of spleen injury in patients with hemophilia: report of two patients with review of literature.
    Sharma OP; Oswanski MF; Issa NM; Stein DT
    J Emerg Med; 2011 Sep; 41(3):e59-64. PubMed ID: 18439785
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Portugal launches two PRT-FFPs to cover the local demands.
    Seghatchian J; de Sousa G
    Transfus Apher Sci; 2015 Apr; 52(2):226-7. PubMed ID: 25752213
    [No Abstract]   [Full Text] [Related]  

  • 53. Haemophilia.
    Brody H
    Nature; 2014 Nov; 515(7528):S157. PubMed ID: 25427203
    [No Abstract]   [Full Text] [Related]  

  • 54. The Dublin Consensus Statement on vital issues relating to the collection of blood and plasma and the manufacture of plasma products. PLUS.
    Mahony BO; Turner A
    Vox Sang; 2010 Apr; 98(3 Pt 2):447-50. PubMed ID: 20158697
    [No Abstract]   [Full Text] [Related]  

  • 55. [Everyone and nobody has the responsibility for the future of plasma products].
    Sjölin S
    Lakartidningen; 1996 Nov; 93(46):4137, 4139. PubMed ID: 8984263
    [No Abstract]   [Full Text] [Related]  

  • 56. How do we ... integrate transfusion medicine and tissue dispensing programs in an academic medical center: response to a changing regulatory environment.
    Maitta RW; Avery L; Champion M; Vaughn D; Baillargeon C; Lederer J; Snyder EL
    Transfusion; 2012 Jun; 52(6):1172-81. PubMed ID: 21981598
    [No Abstract]   [Full Text] [Related]  

  • 57. Plasma fractions for the treatment of hemophilia. 1. On the preparation and use of fraction I-O.
    Blombäck M; Blombäck B
    Thromb Diath Haemorrh Suppl; 1969; 35():21-5. PubMed ID: 5317539
    [No Abstract]   [Full Text] [Related]  

  • 58. Blood Proteomics. Preface.
    Zolla L
    J Proteomics; 2010 Jan; 73(3):361-4. PubMed ID: 19914409
    [No Abstract]   [Full Text] [Related]  

  • 59. [Therapeutic effect on hemophilia by AMCHA].
    Gebauer D; Heigel K
    Med Klin; 1969 Feb; 64(9):378-82. PubMed ID: 5305740
    [No Abstract]   [Full Text] [Related]  

  • 60. Hemovigilance in Massachusetts and the adoption of statewide hospital blood bank reporting using the National Healthcare Safety Network.
    Cumming M; Osinski A; O'Hearn L; Waksmonski P; Herman M; Gordon D; Griffiths E; Knox K; McHale E; Quillen K; Rios J; Pisciotto P; Uhl L; DeMaria A; Andrzejewski C
    Transfusion; 2017 Feb; 57(2):478-483. PubMed ID: 27774608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.